3 results
Approved WMOCompleted
The primary study objective is to assess the proportion of patients who remain within the IGF-I age adjusted normal limits with pasireotide LAR (60 mg) monotherapy, after 24 weeks of treatment.Secondary study objectives are assessment of theā¦
Approved WMOCompleted
Confirm the interaction between colchicine and the choline pathway as seen with FCH-PET.
Approved WMOCompleted
Investigate the distribution, dosimetry and image quality of [195mPt]cisplatin in cancer patients